NDC 0093-5527

Atazanavir Sulfate

Atazanavir Sulfate

Atazanavir Sulfate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Atazanavir Sulfate.

Product ID0093-5527_16b478ff-cfed-4273-9f96-429014275b6c
NDC0093-5527
Product TypeHuman Prescription Drug
Proprietary NameAtazanavir Sulfate
Generic NameAtazanavir Sulfate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-12-27
Marketing CategoryANDA / ANDA
Application NumberANDA091673
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameATAZANAVIR SULFATE
Active Ingredient Strength200 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0093-5527-06

60 CAPSULE in 1 BOTTLE (0093-5527-06)
Marketing Start Date2017-12-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0093-5527-06 [00093552706]

Atazanavir Sulfate CAPSULE
Marketing CategoryANDA
Application NumberANDA091673
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-12-27

Drug Details

Active Ingredients

IngredientStrength
ATAZANAVIR SULFATE200 mg/1

OpenFDA Data

SPL SET ID:654b7e08-33d8-47e7-b37f-3681e79c7b8b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 664741
  • 402246
  • 402247
  • UPC Code
  • 0300935526065
  • 0300935527062
  • 0300935528564
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]
    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]

    NDC Crossover Matching brand name "Atazanavir Sulfate" or generic name "Atazanavir Sulfate"

    NDCBrand NameGeneric Name
    0093-5526Atazanavir SulfateAtazanavir Sulfate
    0093-5527Atazanavir SulfateAtazanavir Sulfate
    0093-5528Atazanavir SulfateAtazanavir Sulfate
    0904-6875Atazanavir SulfateAtazanavir
    16714-860Atazanavir SulfateAtazanavir
    16714-861Atazanavir SulfateAtazanavir
    16714-862Atazanavir SulfateAtazanavir
    51407-171Atazanavir SulfateAtazanavir Sulfate
    51407-172Atazanavir SulfateAtazanavir Sulfate
    51407-173Atazanavir SulfateAtazanavir Sulfate
    60687-399Atazanavir SulfateAtazanavir
    65862-710Atazanavir SulfateAtazanavir
    65862-711Atazanavir SulfateAtazanavir
    65862-712Atazanavir SulfateAtazanavir
    65862-713Atazanavir SulfateAtazanavir
    70518-1365Atazanavir SulfateAtazanavir Sulfate
    70518-0946Atazanavir SulfateAtazanavir Sulfate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.